SIS
NVO

Susquehanna International Securities’s Novo Nordisk NVO Stock Holding History

Susquehanna International Securities’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-157,200
Closed -$5.49M – 28
2020
Q4 		$5.49M Hold
157,200
– – 3.99% 10
2020
Q3 		$5.46M Hold
157,200
– – 2.88% 12
2020
Q2 		$5.15M Sell
157,200
-1,800
-1% -$57.4K 2.13% 13
2020
Q1 		$4.79M Sell
159,000
-37,800
-19% -$1.13M 1.94% 13
2019
Q4 		$5.7M Buy
196,800
+55,000
+39% +$1.52M 2.16% 15
2019
Q3 		$3.67M Sell
141,800
-90,200
-39% -$2.28M 0.8% 39
2019
Q2 		$5.92M Buy
232,000
+158,200
+214% +$3.91M 1.92% 17
2019
Q1 		$1.93M Buy
+73,800
New +$1.81M 0.47% 42

Other funds holding NVO

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Susquehanna International Securities's NVO Position: Q1 2024 in Review

Susquehanna International Securities sold out of Novo Nordisk (NVO) in Q1 2024, closing a stake of 3,456 shares — an estimated $358K sold.

Susquehanna International Securities first reported a position in NVO in Q1 2019 and held it in 7 quarters. The position peaked at $4.65M in Q3 2019. 1,745 funds tracked by Wall St. Rank hold NVO as of Q1 2024.

  • Susquehanna International Securities reported no remaining Novo Nordisk position as of Q1 2024 after selling out during the quarter.
  • Susquehanna International Securities sold 3,456 Novo Nordisk shares in Q1 2024, an estimated $358K.
  • Susquehanna International Securities first reported a position in Novo Nordisk in Q1 2019 and held it in 7 quarters.
  • Susquehanna International Securities's Novo Nordisk position peaked at $4.65M in Q3 2019.
  • 1,745 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2024.

Based on Susquehanna International Securities's 13F filing for Q1 2024, filed 7 May 2024.